Skip to main content
Clinical Trials/NCT02923973
NCT02923973RecruitingNot Applicable

Transvaginal Ultrasound Cervical Length Screening in Singleton Pregnancy With Prior Spontaneous Preterm Birth

Federico II University3 sites in 1 country500 target enrollmentStarted: June 1, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
500
Locations
3
Primary Endpoint
Preterm delivery

Study Overview

Brief Summary

Preterm birth (PTB) is the major cause of perinatal morbidity and mortality. Worldwide, about 15 million babies are born too soon every year, causing 1.1 million deaths, as well as short- and long-term disability in countless survivors. Few prognostic tests are available to predict PTB. A short transvaginal ultrasound cervical length (TVU CL) has been shown to be a good predictor of PTB.Different strategies have been adopted for prevention of PTB. The evidence supports the use of vaginal progesterone in singleton pregnancies with short cervix, while cervical cerclage seems to be beneficial only in the subgroup of singleton gestations with both prior spontaneous PTB and TVU CL ≤25mm, and not in singletons without prior PTB, nor in multiple gestations.

However, so far there are no level-1 data on the efficacy of TVU CL screening neither in low risk nor in high risk pregnancy Thus, the investigators aim to assess the efficacy of a policy of TVU CL screening in singleton pregnancy with prior spontaneous PTB

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 18-50 years of age
  • Singleton gestations
  • Women with prior spontaneous preterm birth, defined as spontaneous preterm delivery 16 0/7 - 36 6/7 weeks

Exclusion Criteria

  • multiple gestation
  • Ruptured membranes or fetal structural or chromosomal abnormality at the time of randomization
  • Ballooning of membranes outside the cervix into the vagina at the time of randomization
  • Labor or cerclage in situ at the time of randomization

Outcomes

Primary Outcomes

Preterm delivery

Time Frame: Less than 37 weeks gestation

Secondary Outcomes

  • Neonatal death(Between birth and 28 days of age)
  • Low birth weight(Time of delivery)
  • Composite adverse neonatal outcome(Between birth and 28 days of age)
  • Admission to neonatal intensive care unit(Between birth and 28 days of age)
  • Gestational age at delivery(Time of delivery)
  • preterm birth rates(Less than 24, 28, 34 weeks gestation)
  • Birth weight(Time of delivery)

Investigators

Sponsor
Federico II University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Gabriele Saccone

MD

Federico II University

Study Sites (3)

Loading locations...

Similar Trials